Abcam appoints new CEO

Abcam, a leading provider of innovative protein research tools and services, announced the appointment of Mr Alan Hirzel as its new CEO with immediate effect


Mr Alan Hirzel

Mr Alan will succeed long-serving CEO and co-founder of Abcam, Mr Jonathan Milner, who will continue to play an active role in the company as deputy chairman, who is the company's largest shareholder.

He takes on the role of CEO having spent the last year as chief marketing officer of Abcam, and he has served on the board since January 2014.

In this role Mr Alan has the responsibility for the company's branding, product portfolio and online consumer offering.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email